3 billion in 2014.

Related StoriesHealthcare technology interpersonal event of the entire year opens entriesTWi Biotechnology gets notice of patent allowance covering usage of AC-201 medication in diabetes treatmentApplying a high restaurant model to healthcare communications: an interview with Brandi Robinson, SanofiUnder the Bioeconomy Accelerator Program, BiotechCorp partnered with Larta Institute in LA to mentor Malaysian companies bringing in their products to USA and set up strategic partnerships to improve their product worth.The number of deaths associated with pneumococcal disease in this study was too small to permit a meaningful evaluation of the effect of the vaccine . Analyses of the secondary and primary end points according to serotype are summarized in Tables S10, S11, and S12 in the Supplementary Appendix. Furthermore, the results of the analysis of vaccine efficacy relating to age against first episodes of vaccine-type community-acquired pneumonia are shown in Table S3 in the Supplementary Appendix. Post hoc analyses of the principal and secondary end factors where the cumulative amount of episodes had been plotted against the time from vaccination provided evidence of efficacy beginning soon after vaccination.